Patients with neuroblastoma who are eligible for MIBG therapy may include:
- Patients who have had poor response to chemotherapy;
- Patients whose disease has progressed while on chemotherapy; or
- Patients whose disease has come back after initial therapy.
MIBG therapy is only one piece to your child’s overall neuroblastoma treatment.
Patients with pheochromocytoma or paraganglioma may also be eligible for MIBG therapy.